ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Cellular Biomedicine Group, Inc.
August 13 2020 - 3:25PM
Business Wire
Rowley Law PLLC is investigating potential securities law
violations by Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) and
its board of directors concerning the proposed acquisition of the
company by members of Cellular Biomedicine Group’s senior
management and other investors. Stockholders will receive $19.75 in
cash for each share of Cellular Biomedicine Group stock that they
hold. The transaction is expected to close in the fourth quarter of
2020.
If you are a stockholder of Cellular Biomedicine Group, Inc. and
are interested in obtaining additional information regarding this
investigation, please visit us at:
http://www.rowleylawpllc.com/investigation/cbmg/. You may
also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street
Suite 1000, White Plains, NY 10606, by email at
info@rowleylawpllc.com, or by telephone at 914-400-1920 or
844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200813005755/en/
Shane Rowley, Esq. Rowley Law PLLC 50 Main Street Suite 1000
White Plains, NY 10606 info@rowleylawpllc.com 914-400-1920 or
844-400-4643 (toll-free)
Cellular Biomedicine (NASDAQ:CBMG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cellular Biomedicine (NASDAQ:CBMG)
Historical Stock Chart
From Apr 2023 to Apr 2024